Search research articles
Contact Us
Filters
Showing results (171-180 of 191) with videos related to
Page
of 20
Sort By:
Neurobiology of Aging
|
September 21, 2024
Resting-state functional connectivity abnormalities in subjective cognitive decline: A 7T MRI study
M Pievani, F Ribaldi, K Toussas, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
December 21, 2004
A voxel based morphometry study on mild cognitive impairment
C Pennanen, C Testa, M P Laakso, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 6, 2021
2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework
A Leuzy, N J Ashton, N Mattsson-Carlgren, et al.
The Gerontologist
|
September 3, 1998
Special care units for demented patients: a multicenter study
G Bellelli, G B Frisoni, A Bianchetti, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 7, 2021
The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers
N J Ashton, A Leuzy, T K Karikari, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 19, 2004
Frontotemporal dementia: impact of P301L tau mutation on a healthy carrier
A Alberici, C Gobbo, A Panzacchi, et al.
European Journal of Neurology
|
July 27, 2020
A European Academy of Neurology guideline on medical management issues in dementia
K S Frederiksen, C Cooper, G B Frisoni, et al.
European Journal of Neurology
|
August 21, 2012
EFNS task force: the use of neuroimaging in the diagnosis of dementia
M Filippi, F Agosta, F Barkhof, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 23, 2009
White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study
L A van de Pol, F Verhey, G B Frisoni, et al.
Journal of Internal Medicine
|
July 10, 2019
Current and emerging avenues for Alzheimer's disease drug targets
R Loera-Valencia, A Cedazo-Minguez, P A Kenigsberg, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 191) with videos related to
Sort By:
Page
of 20
Neurobiology of Aging
|
September 21, 2024
Resting-state functional connectivity abnormalities in subjective cognitive decline: A 7T MRI study
M Pievani, F Ribaldi, K Toussas, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
December 21, 2004
A voxel based morphometry study on mild cognitive impairment
C Pennanen, C Testa, M P Laakso, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 6, 2021
2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework
A Leuzy, N J Ashton, N Mattsson-Carlgren, et al.
The Gerontologist
|
September 3, 1998
Special care units for demented patients: a multicenter study
G Bellelli, G B Frisoni, A Bianchetti, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 7, 2021
The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers
N J Ashton, A Leuzy, T K Karikari, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 19, 2004
Frontotemporal dementia: impact of P301L tau mutation on a healthy carrier
A Alberici, C Gobbo, A Panzacchi, et al.
European Journal of Neurology
|
July 27, 2020
A European Academy of Neurology guideline on medical management issues in dementia
K S Frederiksen, C Cooper, G B Frisoni, et al.
European Journal of Neurology
|
August 21, 2012
EFNS task force: the use of neuroimaging in the diagnosis of dementia
M Filippi, F Agosta, F Barkhof, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 23, 2009
White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study
L A van de Pol, F Verhey, G B Frisoni, et al.
Journal of Internal Medicine
|
July 10, 2019
Current and emerging avenues for Alzheimer's disease drug targets
R Loera-Valencia, A Cedazo-Minguez, P A Kenigsberg, et al.
Page
of 20